Caplin Point Labs 35th AGM: All 6 resolutions passed with strong majority

Board & Shareholder Meetings View source PDF Explain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹2835.00

prior close

₹2856.70

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.6%+2.2% vs market

Pharmaceuticals peers, median of 172sector-1.5%+2.0% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.1

15m

-1.8

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-1.6+2.2-1.5+2.0

Next day

-3.4-2.3-1.2-1.0-2.5

-4.4-2.0-2.4-1.9-2.5

-7.9-3.1-4.7-2.4-5.5

-8.8-2.8-6.0-3.2-5.6

-5.5-1.4-4.1-2.4-3.1

-10.4-3.7-6.7-4.2-6.2

15d

-21.7-6.2-15.5-7.8-13.9

-16.7pendingpending-6.4-10.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Caplin Point Labs held its 35th AGM on September 25, 2026. All 6 resolutions passed with strong shareholder approval. Adoption of FY26 financial statements got 100% in favor. Final dividend ratification also got 100%. Re-appointment of Dr. Sridhar Ganesan as Director got 99% and as Managing Director got 98.94%. Continuation of Mr. C.C. Paarthipan as Chairman got 98.72%. Appointment of Mr. D Muralidharan as Whole Time Director got 96.78%.

Likely market impact

Smooth AGM with all resolutions passed. No governance red flags. Dividend confirmed for shareholders.